PETER CLAUSEN - 20 May 2024 Form 4 Insider Report for Nuo Therapeutics, Inc. (AURX)

Role
CSO/COO
Signature
/s/ David E. Jorden, attorney-in-fact
Issuer symbol
AURX
Transactions as of
20 May 2024
Net transactions value
+$11,250
Form type
4
Filing time
21 May 2024, 15:13:21 UTC
Previous filing
20 Dec 2023
Next filing
04 Aug 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AURX Common Stock Award $11,250 +15,000 +2.6% $0.7500 586,201 20 May 2024 Direct F1
holding AURX Common Stock 3,474 20 May 2024 By spouse
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Transaction approved by Board of Directors of Issuer and Non-Employee Directors